Inhibitory effect of supramolecular polyrotaxane-dipeptide conjugates on digested peptide uptake via intestinal human peptide transporter

Bioconjug Chem. 2002 May-Jun;13(3):582-7. doi: 10.1021/bc015567z.

Abstract

The effect of polyrotaxane-dipeptide (Val-Lys) conjugates on the uptake of a model dipeptide (Gly-Sar) was examined via human peptide transporter (hPEPT1) on HeLa cells. Here, Val-Lys groups are introduced to alpha-CDs, which are threaded onto a poly(ethylene oxide) chain capped with bulky end-groups (polyrotaxane). The Gly-Sar uptake via hPEPT1 was significantly inhibited in the polyrotaxane conjugates, and this inhibitory effect was not explained by the sum of interaction between hPEPT1 and alpha-CD-Val-Lys conjugates. Further, the inhibition was significantly greater than those observed in dextran-Val-Lys conjugates. Therefore, our data clearly suggests that supramolecular structure in the polyrotaxane conjugates contributes considerably to the inhibitory effect via multivalent binding of Val-Lys groups with hPEPT1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • Carrier Proteins / metabolism*
  • Cyclodextrins / chemistry
  • Cyclodextrins / metabolism
  • Dipeptides / antagonists & inhibitors
  • Dipeptides / metabolism*
  • Fluorescent Dyes / chemistry
  • HeLa Cells / drug effects
  • HeLa Cells / metabolism
  • Humans
  • Magnetic Resonance Spectroscopy
  • Peptide Fragments / metabolism
  • Peptide Transporter 1
  • Polycyclic Compounds / pharmacology
  • Polyethylene Glycols / chemistry
  • Polyethylene Glycols / metabolism
  • Rotaxanes
  • Symporters*

Substances

  • Carrier Proteins
  • Cyclodextrins
  • Dipeptides
  • Fluorescent Dyes
  • Peptide Fragments
  • Peptide Transporter 1
  • Polycyclic Compounds
  • Rotaxanes
  • SLC15A1 protein, human
  • Symporters
  • valyllysine
  • glycylsarcosine
  • Polyethylene Glycols